Literature DB >> 17591925

The CpG island methylator phenotype in colorectal cancer.

Wade S Samowitz1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17591925      PMCID： PMC1899417          DOI： 10.2353/jmoldx.2007.070031

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN： 1525-1578            Impact factor:   5.568


× No keyword cloud information.
  19 in total

1.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.

Authors:  M Toyota; M Ohe-Toyota; N Ahuja; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.

Authors:  Nicholas Hawkins; Mark Norrie; Kay Cheong; Elisa Mokany; Su-Lyn Ku; Alan Meagher; Terence O'Connor; Robyn Ward
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

3.  Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands.

Authors:  M van Rijnsoever; F Grieu; H Elsaleh; D Joseph; B Iacopetta
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

4.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Authors:  T Kambara; L A Simms; V L J Whitehall; K J Spring; C V A Wynter; M D Walsh; M A Barker; S Arnold; A McGivern; N Matsubara; N Tanaka; T Higuchi; J Young; J R Jass; B A Leggett
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

5.  BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.

Authors:  Guoren Deng; Ian Bell; Suzanne Crawley; James Gum; Jonathan P Terdiman; Brian A Allen; Brindusa Truta; Marvin H Sleisenger; Young S Kim
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

6.  BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Authors:  E Domingo; P Laiho; M Ollikainen; M Pinto; L Wang; A J French; J Westra; T Frebourg; E Espín; M Armengol; R Hamelin; H Yamamoto; R M W Hofstra; R Seruca; A Lindblom; P Peltomäki; S N Thibodeau; L A Aaltonen; S Schwartz
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

7.  Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.

Authors:  A McGivern; C V A Wynter; V L J Whitehall; T Kambara; K J Spring; M D Walsh; M A Barker; S Arnold; L A Simms; B A Leggett; J Young; J R Jass
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

8.  Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.

Authors:  Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Peter Kraft; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

9.  Genetics supersedes epigenetics in colon cancer phenotype.

Authors:  Kentaro Yamashita; Tomoko Dai; Yuichi Dai; Fumiichiro Yamamoto; Manuel Perucho
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

10.  Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.

Authors:  Harith Rajagopalan; Alberto Bardelli; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962
View more
  22 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  Effects of supplemental calcium and vitamin D on tight-junction proteins and mucin-12 expression in the normal rectal mucosa of colorectal adenoma patients.

Authors:  Hannah B Mandle; Ferdous A Jahan; Roberd M Bostick; John A Baron; Elizabeth L Barry; Rami Yacoub; Julia Merrill; Robin E Rutherford; March E Seabrook; Veronika Fedirko
Journal:  Mol Carcinog       Date:  2019-04-02       Impact factor: 4.784

Review 3.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

Review 4.  Accumulation of aberrant DNA methylation during colorectal cancer development.

Authors:  Eiji Sakai; Atsushi Nakajima; Atsushi Kaneda
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

5.  PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

Authors:  Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Wolfram Goessling; Andrew T Chan; Kimmie Ng; Jennifer A Chan; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

6.  Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer.

Authors:  Elizabeth M Poole; Karen Curtin; Li Hsu; David J Duggan; Karen W Makar; Liren Xiao; Christopher S Carlson; Bette J Caan; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Cancer Epidemiol       Date:  2011-12-06       Impact factor: 2.984

7.  Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer.

Authors:  Elizabeth M Poole; Karen Curtin; Li Hsu; Richard J Kulmacz; David J Duggan; Karen W Makar; Liren Xiao; Christopher S Carlson; Martha L Slattery; Bette J Caan; John D Potter; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2011-12-03

8.  Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.

Authors:  Karen Curtin; Wade S Samowitz; Roger K Wolff; Cornelia M Ulrich; Bette J Caan; John D Potter; Martha L Slattery
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

9.  Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells.

Authors:  Natsumi Irahara; Katsuhiko Nosho; Yoshifumi Baba; Kaori Shima; Neal I Lindeman; Aditi Hazra; Eva S Schernhammer; David J Hunter; Charles S Fuchs; Shuji Ogino
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

10.  The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.

Authors:  Wade S Samowitz; Karen Curtin; Roger K Wolff; Hans Albertsen; Carol Sweeney; Bette J Caan; Cornelia M Ulrich; John D Potter; Martha L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2008-10       Impact factor: 5.006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.